Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Use of risperidone in children with epilepsy|
|Abstract:||Objective. Although the atypical antipsychotic medications appear to be safe in patients with epilepsy, few studies have specifically addressed the use of risperidone in children with seizures. The objective of this study was to evaluate behavior improvement and seizure outcome in children with epilepsy and behavioral disorders (self-injurious, aggressive, or destructive behavior) after introduction of risperidone. Methods. In this prospective study, 54 patients were evaluated, 38 boys and 16 girls, aged 2-18 (mean = 10). The dose of risperidone ranged from 0.01 to 0.14 mg/kg/day (mean = 0.038 mg/kg/day). Risperidone was introduced gradually. The titration rate was determined by clinical response. The data were collected from patients' follow-up visits and clinical files. Exacerbation of seizures was established as an increase in seizure frequency after introduction of risperidone, with return to baseline seizure frequency after risperidone withdrawal. Results. Seizure frequency was not affected by risperidone in 51 patients (94.5%). Only two (4%) patients experienced seizure exacerbation after the introduction of risperidone. In one patient, the effect of risperidone on seizure control could not be established. After introduction of the risperidone, 38 (70.4%) patients manifested improvement in behavior. Conclusion. Our data suggest that risperidone can be used in pediatric patients with epilepsy and that seizure outcome is not changed in most children with epilepsy and psychiatric comorbidity. In addition, behavior improvement is usually achieved in most patients. (C) 2007 Elsevier Inc. All rights, reserved.|
|Editor:||Academic Press Inc Elsevier Science|
|Citation:||Epilepsy & Behavior. Academic Press Inc Elsevier Science, v. 10, n. 3, n. 412, n. 416, 2007.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.